Immunization Coalition of Delaware
Immunization is one of the most effective public health prevention strategies!
August 21, 2023. Fenit Nirappil, Washington Post Federal regulators on Monday approved a maternal RSV vaccine administered during pregnancy to protect infants from severe illness. It’s the latest in a new arsenal of immunizations against the common respiratory virus that is the leading cause of hospitalization in young children and kills thousands of seniors annually. Read more.
Today, ACIP voted unanimously (10 YES – 0 NO for all votes) to recommend nirsevimab for use in infants <8 months born or entering their first RSV season, and for children aged 8-19 months who are at increased risk of RSV disease entering their second RSV season (agenda and slides). The Committee also voted for the inclusion of nirsevimab in VFC: Infants aged <8 months born during or entering their first RSV reason are recommended to receive one dose of nirsevimab (50 mg for infants <5 kg and 100 mg for infants ≥5kg) Children aged 8-19 months who are at Read More …
National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the importance of routine vaccination for people of all ages. Use these resources to help you discuss routine vaccinations with your patients and parents during NIAM and throughout the year. Check out the toolkit here!
April 3-7, 2022 Learn more from Unity (United for Adolescent Vaccination).
Free, 1-hour webinar hosted by ImmunizeOrg, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults” at 1 p.m. ET on Feb 28. Anxiety about needles and injections affects as many as 2 out of 3 children and 1 out of 4 adults; this anxiety can contribute to dreading, delaying, or avoiding vaccinations, even when the importance of preventing illness is understood. The good news is that there are safe, effective, and practical steps that those who administer vaccines and vaccine recipients or their caregivers can take to reduce vaccination-related pain and anxiety and increase confidence in vaccination. Read More …
DOVER, DE (Sept. 29, 2022) – October 2 marks the official start of the 2022-2023 influenza (flu) season. The flu vaccine plays a pivotal role in helping to avoid significant flu-related illnesses, including hospitalization and death. The Delaware Division of Public Health (DPH) believes it is vital for Delawareans to protect themselves and their loved ones by getting the flu vaccine as soon as possible, particularly given the ongoing battle against COVID-19 and a potentially active flu season ahead. The U.S. often looks to the experience of Australia and New Zealand in the Southern Hemisphere during their flu season in the summer as a possible Read More …
New data in JAMA report that 90 people who received monkeypox vaccine — Jynneos, made by Bavarian Nordic — through their clinics from late June to September contracted the virus. Most of those people (77%) tested positive in the first 14 days after their first dose, a time during which their immune responses to the vaccine were still developing. But 21 people contracted the virus after 14 days, eight after 28 days, and two contracted monkeypox three weeks or more after receiving both doses of the vaccine. During the study period, 7,339 people received a first dose at the clinics. Read More …
DOVER, DE (Sept 22, 2022) – The Delaware Division of Public Health (DPH) is sharing upcoming opportunities for individuals to get vaccinated against the monkeypox virus (MPX). The current case count for MPX in the state is 35, including 23 cases in New Castle County, three cases in Kent County, and nine cases in Sussex County. Delaware continues to offer vaccinations to people at a higher risk of exposure. Vaccine eligibility is being expanded to include all gay, bisexual and transgender or nonbinary persons having sex with men, or females having sex with gay, bisexual, non-binary, or transgender males. Delaware is also expanding vaccine eligibility to health care workers Read More …
The CDC has just released the National Vaccination Coverage Among Adolescents Aged 13-17 Years, 2021. “Among adolescents aged 13–17 years in 2021, HPV vaccination coverage (≥1 dose and HPV vaccine up to date) increased. Coverage with ≥1-dose Tdap and ≥1-dose MenACWY remained high. Among age-eligible adolescents, MenACWY booster dose coverage increased. Analyses of the potential COVID-19 pandemic effect among adolescents born in 2008 show a concerning decrease in ≥1 MenACWY and ≥1 Tdap dose coverage.” Read more
CDC RAISES DELAWARE’S COVID-19 COMMUNITY LEVELS TO HIGH IN ALL COUNTIES; DPH ENCOURAGES MASKING IN INDOOR PUBLIC SETTINGS AND VACCINATION DOVER, DE (July 29, 2022) – The Centers for Disease Control and Prevention (CDC) raised Delaware’s COVID-19 community levels to the High category (red) in all three counties on July 28, 2022. As a result, the Division of Public Health (DPH) is asking Delawareans to follow the CDC’s key strategies at this level of community spread: · Wear a well-fitting mask in indoor public settings, regardless of vaccination status. · Stay home if you are sick and get tested if you have symptoms or Read More …